Co-Diagnostics Inc
For the period ended Dec 31, 2023. Filed Mar 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 14, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CO-DIAGNOSTICS, INC. | ||
| Date: March 14, 2024 | By: | /s/ Dwight Egan |
|---|---|---|
| Dwight Egan | ||
| Chief Executive Officer, President and Director (Principal Executive Officer) | ||
| By: | /s/ Brian Brown | |
| Brian Brown Chief Financial Officer (Principal Financial and Accounting Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Dwight Egan | Chief Executive Officer, President and Director | March 14, 2024 |
| Dwight Egan | (Principal Executive Officer) | |
| /s/ Brian Brown | Chief Financial Officer | March 14, 2024 |
| Brian Brown | (Principal Financial and Accounting Officer) | |
| /s/ Eugene Durenard | Director | March 14, 2024 |
| Eugene Durenard | ||
| /s/ Edward Murphy | Director | March 14, 2024 |
| Edward Murphy | ||
| /s/ James Nelson | Director | March 14, 2024 |
| James Nelson | ||
| /s/ Richard Serbin | Director | March 14, 2024 |
| Richard Serbin | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.